Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Innoviva (INVA) EBITDA (2016 - 2025)

Historic EBITDA for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $34.6 million.

  • Innoviva's EBITDA fell 2002.68% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.6 million, marking a year-over-year decrease of 2036.32%. This contributed to the annual value of $7.8 million for FY2024, which is 8074.46% down from last year.
  • Innoviva's EBITDA amounted to $34.6 million in Q3 2025, which was down 2002.68% from $48.8 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's EBITDA ranged from a high of $96.5 million in Q2 2021 and a low of -$11.3 million during Q1 2023
  • Over the past 5 years, Innoviva's median EBITDA value was -$6.0 million (recorded in 2021), while the average stood at $18.5 million.
  • Per our database at Business Quant, Innoviva's EBITDA plummeted by 10955.04% in 2022 and then surged by 151530000.0% in 2023.
  • Quarter analysis of 5 years shows Innoviva's EBITDA stood at -$6.0 million in 2021, then tumbled by 70.77% to -$10.3 million in 2022, then skyrocketed by 36.31% to -$6.6 million in 2023, then plummeted by 60.22% to -$10.5 million in 2024, then skyrocketed by 428.1% to $34.6 million in 2025.
  • Its EBITDA stands at $34.6 million for Q3 2025, versus $48.8 million for Q2 2025 and -$8.2 million for Q1 2025.